Directory

>

Christopher Frankenfield

avatar

Christopher Frankenfield

Chief Financial Officer and Chief Operating Officer | Xilio Therapeutics, Inc.

United States

View contact details (it's free)

Christopher Frankenfield

Summary

Christopher Frankenfield is a seasoned executive with extensive experience in the legal and management consulting sectors. As the Chief Operating Officer at Xilio Therapeutics, he leverages his background in corporate law and governance to drive strategic initiatives and operational efficiency. With a career spanning over two decades, Christopher has held various leadership roles, including Chief Legal and Administrative Officer and Vice President of Corporate Legal Affairs, where he has been instrumental in mergers, acquisitions, and corporate strategy. He holds a Juris Doctor from the University of Virginia and a Bachelor's degree in Economics and Finance from the College of William & Mary. His expertise encompasses a broad range of areas including finance, due diligence, and venture capital, making him a versatile leader in the commercial physical research industry. Christopher has also contributed to academic discourse through publications in health care law, showcasing his commitment to thought leadership. His ability to navigate complex legal landscapes while fostering innovation sets him apart in his field.

General

Generalist

Leadership Experience

Long-Term Tenure

Professional interests

Industry-specific interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Corporate Experience

Consulting Experience

Christopher Frankenfield

Work Experience

company logo

Chief Financial Officer and Chief Operating Officer at

Xilio Therapeutics, Inc.

August 2024 - Present

company logo

Chief Operating Officer at

Xilio Therapeutics, Inc.

August 2023 - August 2024

company logo

Chief Legal and Administrative Officer at

Xilio Therapeutics, Inc.

August 2022 - August 2023

company logo

Senior Vice President and General Counsel at

Xilio Therapeutics, Inc.

March 2021 - August 2022

company logo

Vice President, Corporate Legal Affairs at

Blueprint Medicines

July 2019 - March 2021

company logo

Senior Corporate Counsel at

Blueprint Medicines

July 2017 - July 2019

company logo

Corporate Counsel at

Blueprint Medicines

August 2015 - July 2017

company logo

Senior Associate at

Wilmer Cutler Pickering Hale and Dorr LLP

March 2010 - August 2015

company logo

Summer Associate at

Wilmer Cutler Pickering Hale and Dorr LLP

May 2008 - July 2008

company logo

Summer Associate at

Kilpatrick Townsend & Stockton LLP

May 2007 - July 2007

company logo

Associate - Advisory Practice (Dispute Analysis & Investigations) at

PwC

August 2004 - July 2006

company logo

Intern - Regulatory Department at

Amerigroup

May 2003 - August 2003

company logo

Intern - Marketing Department at

Dominion Enterprises

June 2002 - August 2002

Logos provided by Logo.dev

Christopher Frankenfield

Education

University of Virginia School of Law, Jd

January 2006 - January 2009

The College of William & Mary, Ba

January 2000 - January 2004

Frequently Asked Questions about Christopher Frankenfield

What is Christopher Frankenfield email address?

Christopher Frankenfield's primary email address is *************@xiliotx.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Christopher Frankenfield work for?

Christopher Frankenfield is a Chief Financial Officer and Chief Operating Officer at Xilio Therapeutics, Inc., a company specializing in Commercial physical research.

Where Christopher Frankenfield graduated from?

Christopher Frankenfield holds a degree in from University of Virginia School of Law.

How can I directly contact Christopher Frankenfield?

To contact Christopher Frankenfield directly, you can use the email address *************@xiliotx.com. Complete contact information is available upon registration with Muraena.

Who is Christopher Frankenfield?

Christopher Frankenfield is a seasoned executive with extensive experience in the legal and management consulting sectors. As the Chief Operating Officer at Xilio Therapeutics, he leverages his background in corporate law and governance to drive strategic initiatives and operational efficiency. With a career spanning over two decades, Christopher has held various leadership roles, including Chief Legal and Administrative Officer and Vice President of Corporate Legal Affairs, where he has been instrumental in mergers, acquisitions, and corporate strategy. He holds a Juris Doctor from the University of Virginia and a Bachelor's degree in Economics and Finance from the College of William & Mary. His expertise encompasses a broad range of areas including finance, due diligence, and venture capital, making him a versatile leader in the commercial physical research industry. Christopher has also contributed to academic discourse through publications in health care law, showcasing his commitment to thought leadership. His ability to navigate complex legal landscapes while fostering innovation sets him apart in his field.

Christopher`s contact details

mail

*************@xiliotx.com

*************@blueprintmedicines.com

Colleagues

avatar
Sean Ring

Senior Vice President, Corporate Development and Program Leadership

avatar
Teleen Norman

Senior Vice President Clinical Operations

avatar
Fraser Leslie

Senior Vice President Tech Ops

avatar
Rene Russo

Director

avatar
Scott Coleman

Chief Development Officer (CDO)

avatar
Scott Mcconnell

Vice President Clinical Science and Pharmacovigilance

avatar
Katarina Luptakova

Chief Medical Officer

avatar
Carl Uli Bialucha

Chief Scientific Officer

avatar
Margaret Karow

Founder and Chief Development Office

View Contact details (it's free)
Request Profile Removal